|
Dodgers manager Joe Torre said: "Whatever has to be done to gain the full trust of the fans, we have to do what we can." Blood samples will be collected after games by the National Center for Drug Free Sport, the organization that currently collects urine samples in the minor leagues. The blood samples will be taken from the non-dominant arm of players who are not members of a major league team's 40-man roster, and sent to a testing laboratory in Salt Lake City for analysis. Dr. Gary Green, the medical director for Major League Baseball, called the testing "a major development in the detection of a substance that has previously been undetectable." "The combination of widespread availability and the lack of detection have led to reports of use of this drug amongst athletes," Green said. "This is the first generation of HGH testing and Major League Baseball will continue to fund the Partnership for Clean Competition for ongoing research to refine testing procedures in this area." The Partnership for Clean Competition is a coalition of MLB, the NFL, USADA and the U.S. Olympic Committee that funds research for drug testing. The NFL doesn't currently conduct blood tests for performance-enhancing drugs. But the league has recently said it would like to begin such tests, while the union has long been against them. With the current collective-bargaining contract due to expire in March, the issue is expected to be a key point in upcoming negotiations.
AP Sports Writer Eddie Pells, Dave Skretta and Ronald Blum contributed to this report.
Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor